Healogics Inc. today announced their support of the American Diabetes Association (ADA) Compendium Diagnosis and Management of Diabetic Foot Ulcer Complications through an unrestricted educational grant1.
JACKSONVILLE, Fla., Oct. 17, 2018 /PRNewswire/ -- Healogics Inc., the nation’s largest provider of advanced wound care services, today announced their support of the American Diabetes Association (ADA) Compendium Diagnosis and Management of Diabetic Foot Ulcer Complications through an unrestricted educational grant1. More than 30 million people across the U.S. are living with diabetes, and foot problems including foot ulcers are common complications that, without proper treatment, can lead to hospital admissions and even amputations. The ADA Compendium was compiled by a panel of contributing authors and distributed this month to health care professionals who subscribe to the ADA’s peer-reviewed journals Diabetes Care and Diabetes. Healogics is passionate about providing wound care for the 25 percent of diabetics who will experience a foot ulcer at some point in their life2.
“We are proud to support the ADA in their efforts to better understand the latest evidence for treating diabetic foot ulcers,” said David Bassin, Healogics Chief Executive Officer. “We are thrilled that through our unrestricted grant to the ADA, the Compendium was published with a focus on diabetic foot complications.”
The Compendium has been distributed to Healogics’ 4,000 affiliated physicians and will be distributed to thousands more who entrust their patients care to Healogics Wound Care Centers across the country.
An estimated 15 percent of those with a diabetic foot ulcer will experience an amputation3
Over the past year, Healogics has sought to advance the science, awareness and practice of wound care through the Wound Science Initiative SM. The Wound Science Initiative includes collaborations such as this one with advocacy organizations including the ADA and other academic and scientific leaders. Healogics seeks to unite and educate key stakeholders across the healthcare environment to ensure that chronic wound patients receive the highest quality evidence-based care. These aims will be achieved by leveraging Healogics vast clinical database of over three million records to advance the science and practice of wound care through research, technology and collaboration.
Patients with an amputation have a 50 percent mortality rate within five years4
Healogics’ support of the ADA includes advertising in print and digital publications, including Diabetes Care, Clinical Diabetes and Diabetes Forecast and events at future scientific symposiums. “Diabetic foot ulcers are an extraordinarily common problem for those living with diabetes, and unfortunately, only a small part of the larger conversation regarding diabetes management addresses the issue of chronic, non-healing wounds,” said William Ennis, DO, MBA, MMM, Healogics Chief Medical Officer. “As it stands today, foot ulcers precede a significant portion of amputations among people living with diabetes. This Compendium has reached scientists, physicians and consumers alike with a powerful message about the importance of specialized wound care.”
About Healogics
Headquartered in Jacksonville, Fla., Healogics is the nation’s wound healing expert. Last year over 330,000 patients received advanced wound care through a nationwide network of nearly 700 Wound Care Centers®. The Healogics team is made up of almost 3,000 employees, 4,000 affiliated physicians and a Healogics Specialty Physician practice group of nearly 300. In addition to the company’s network of outpatient Centers, Healogics partners with over 300 skilled nursing facilities to care for patients with chronic wounds, and provides inpatient consults at more than 80 partner hospitals. As the industry leader, Healogics has the largest repository of chronic wound-specific patient data in the country. The Healogics Wound Science Initiative, an effort launched in 2017 to provide peer-reviewed research, recognizes the value and relevance of big data and advanced analytics to drive continuous, collaborative learning towards a better understanding of how to efficiently utilize healthcare resources for patients with wounds. For additional information, please visit Healogics.com.
Sources:
- Boulton AJM, Armstrong DG, Kirsner RS, et. al. Diagnosis and Management of Diabetes Foot Complications is published by the American Diabetes Association. The content was developed by and includes the opinions of the authors and does not reflect or represent the policy or position of the American Diabetes Association, any of its board or committees, or any of its journals or their editors or editorial boards.
- Sen, Chandan K., Gayle M. Gordillo, Sashwati Roy, Robert Kirsner, and Lynn Lambert. “Human Skin Wounds: A Major and Snowballing Threat to Public Health and the Economy.” Wound Repair Regen. 17, no. 6 (2009): 763-71.
- https://www.amputee-coalition.org/wp-content/uploads/2014/09/2015_annual_report.pdf
- http://www.safw.ch/images/safw/dokumente/POM_2017_02_Hoffmann_Diab-amputation_survival.pdf
View original content to download multimedia:http://www.prnewswire.com/news-releases/healogics-provides-unrestricted-educational-grant-to-support-an-american-diabetes-association-compendium-diagnosis-and-management-of-diabetic-foot-complications-300732789.html
SOURCE Healogics, Inc.
